Sleep Apnea in Patients With MGUS and MM
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorMichael Tomasson
About this trial
This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bone marrow specimens. Specimens will be obtained at the time that patients undergo a standard-of-care procedure in order to minimize discomfort and reduce any risk.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Bone Marrow Aspirate and Biopsy
Treatment groups
200 Participants
are divided into 4 treatment groupsSponsors and collaborators
Michael Tomasson
Lead sponsor
University of Iowa
Sponsor institution
Department of Health and Human Services
Collaborator
Source ClinicalTrials.gov